Global Ablation Technology Market Report and Forecast 2025-2034

Global Ablation Technology Market Outlook

The global ablation technology market size attained a value of 6.05 billion in 2024. The market is expected to grow at a CAGR of 9.8% between 2025 and 2034, reaching almost 14.0 billion by 2034.

Ablation Technology: Introduction

Ablation technology is used in ablation therapy which is a minimally invasive tissue to destroy (ablate) an abnormal tissue present in any condition. The abnormal tissue can be destroyed through various techniques, including heat (radiofrequency), cold (cryoablation), chemicals, or lasers. It is done via a probe that is inserted through the skin, energy beams, or flexible tubes (catheters) inserted through an artery. It is mostly guided with the help of imaging techniques.

Ablation technologies find wide application in multiple domains ranging from surgery to radiation therapies. It causes less pain and allows a shorter recovery span as well as same day discharge in patients.

Global Ablation Technology Market Analysis

The worldwide prevalence of atrial fibrillation has approximately increased by 20%, affecting 0.51%  of the worldwide population. As medications do not always work to reduce the symptoms in many patients, the cardiac practitioners have diverted towards cardiac ablation for the treatment. This is one of the major drivers for ablation technology market demand.

Consequently, there has been active clinical research to bring new advances to the field. For instance, the Heart Rhythm Society announced the efficacy of pulsed field ablation, an alternative to conventional thermal treatment. This is a non-thermal ablation technology that utilizes electrical pulses to cause electroporation and induce cardiac cell death. In addition, in May 2024, Abbott’s TactiFlex™ Ablation Catheter, got approved by the FDA. This device can lead to safer and less time-consuming procedures. Hence, we can anticipate market growth in the ablation technology in the upcoming years.

Emerging technologies like microwave ablation (MWA), cryoablation, radiofrequency ablation (RFA) is also applied in oncological treatments. MWA and cryoablation are gradually growing as a stable alternative to surgical resection for non-small lung cancers, as MWA can control tumour progression while cryoablation extends a patient's survival span. The minimal invasiveness and low risk procedures indicate that the ablation technology market value is set to grow in the forecast period.

Global Ablation Technology Market Segmentation

Market Breakup by Technology

• Radiofrequency Devices

• Laser/Light Ablation

• Ultrasound Devices

• Cryoablation Devices

• Other Devices

Market Breakup by Applications

• Cancer Treatment

• Cardiovascular Disease Treatment

• Ophthalmologic Treatment

• Gynaecological Treatment

• Urological Treatment

• Cosmetic Surgery

• Others

Market Breakup by End User

• Hospitals and Clinics

• Ambulatory Surgical Centers

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global Ablation Technology Market Overview

The North America, especially the United States, has dominated the ablation technology market share in the historical period. The presence of healthcare industry pioneers has played a significant role in driving efficient technical advances for the patients. Currently, major industry leaders like Johnson and Johnson, Medtronic and Boston Scientific Corporation are waiting for their respective pulsed field ablation catheters to be approved by the FDA. Boston Scientific Corporation’s first-generation pulse field ablation device “Farapulse” has already been approved by the EU in 2021. It will fetch FDA’s approval by 2024 tentatively. Similarly, Medtronic’s “Pulse Select” and Johnson & Johnson’s “Varipulse” are in queue as well.

The ablation technology market growth will be swift in the Asia Pacific region owing to the emphasis on the development of a medical technology driven infrastructure. With the availability of affordable resources, it has been welcoming plenty of foreign investments as well. In addition, the geriatric population will be a significant aspect of market growth. It may lead to a boost in the number of surgical procedures where ablation techniques may be applied. Hence, the market will grow in the forecast period.

Global Ablation Technology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbott

• AngioDynamics, Inc. 

• AtriCure, Inc.  

• Boston Scientific Corporation 

• BTG plc  

• Conmed Corporation  

• Johnson & Johnson 

• Medtronic PLC  

• Olympus Corporation  

• Smith & Nephew PLC 

Key Highlights of the Report